Outset Medical Stock (NASDAQ:OM), Analyst Ratings, Price Targets, Predictions

The latest price target for Outset Medical (NASDAQ: OM) was reported by BTIG on April 8, 2024. The analyst firm set a price target for $6.00 expecting OM to rise to within 12 months (a possible 86.34% upside). 13 analyst firms have reported ratings in the last year.

The latest analyst rating for Outset Medical (NASDAQ: OM) was provided by BTIG, and Outset Medical initiated their buy rating.

There is no last upgrade for Outset Medical.

The last downgrade for Outset Medical Inc happened on January 12, 2024 when RBC Capital changed their price target from $14 to $6 for Outset Medical Inc.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Outset Medical, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Outset Medical was filed on April 8, 2024 so you should expect the next rating to be made available sometime around April 8, 2025.

While ratings are subjective and will change, the latest Outset Medical (OM) rating was a initiated with a price target of $0.00 to $6.00. The current price Outset Medical (OM) is trading at is $3.22, which is within the analyst’s predicted range.